Chemoinformaics analysis of (3E)-HEXADECA-1,3-DIEN-5-YNE
Molecular Weight | 218.384 | nRot | 9 |
Heavy Atom Molecular Weight | 192.176 | nRig | 17 |
Exact Molecular Weight | 218.203 | nRing | 0 |
Solubility: LogS | -3.393 | nHRing | 0 |
Solubility: LogP | 4.059 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 42 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 0 |
nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 26 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 16 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
nHA | 0 | APOL | 44.0566 |
nHD | 0 | BPOL | 26.0834 |
QED | 0.278 |
Synth | 3.642 |
Natural Product Likeliness | 1.607 |
NR-PPAR-gamma | 0.969 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0.003 |
Pgp-sub | 0.009 |
HIA | 0.006 |
CACO-2 | -4.793 |
MDCK | 0.0000188 |
BBB | 0.043 |
PPB | 0.998038 |
VDSS | 0.578 |
FU | 0.00639352 |
CYP1A2-inh | 0.964 |
CYP1A2-sub | 0.407 |
CYP2c19-inh | 0.786 |
CYP2c19-sub | 0.057 |
CYP2c9-inh | 0.894 |
CYP2c9-sub | 0.917 |
CYP2d6-inh | 0.564 |
CYP2d6-sub | 0.367 |
CYP3a4-inh | 0.816 |
CYP3a4-sub | 0.18 |
CL | 5.868 |
T12 | 0.552 |
hERG | 0.375 |
Ames | 0.893 |
ROA | 0.609 |
SkinSen | 0.947 |
Carcinogencity | 0.506 |
EI | 0.099 |
Respiratory | 0.276 |
NR-Aromatase | 0.906 |
Antiviral | Yes |
Prediction | 0.764407 |